Table 2.
Outcome | Surgery | Intervention | Est | SE | p | Estpairwise | SEpairwise | Ppairwise |
---|---|---|---|---|---|---|---|---|
BDI | RYGB | Placebo | −8.00 | 3.49 | 0.022 | −0.95 | 4.11 | 0.817 |
Probiotic | −7.05 | 2.17 | 0.001 | |||||
SG | Placebo | −8.55 | 2.69 | 0.002 | 3.22 | 4.25 | 0.449 | |
Probiotic | −11.76 | 3.29 | <0.001 | |||||
HRSD | RYGB | Placebo | −6.43 | 3.86 | 0.096 | −2.40 | 4.59 | 0.601 |
Probiotic | −4.03 | 2.49 | 0.106 | |||||
SG | Placebo | −2.15 | 2.71 | 0.428 | 5.66 | 4.42 | 0.201 | |
Probiotic | −7.80 | 3.50 | 0.026 | |||||
Insomnia | RYGB | Placebo | −3.76 | 2.92 | 0.199 | −1.54 | 3.48 | 0.658 |
Probiotic | −2.21 | 1.89 | 0.242 | |||||
SG | Placebo | −3.54 | 2.09 | 0.090 | −3.05 | 3.40 | 0.370 | |
Probiotic | −0.49 | 2.68 | 0.855 |
Examined contrasts in all cases—Before versus After (After minus Before), BDI—Beck Depression Inventory, HRSD—Hamilton Psychiatric Rating Scale for Depression, RYGB—Roux-en-Y Gastric Bypass, SG—Sleeve Gastrectomy, Est—estimate of average marginal effect (AME), SE—standard error, p—p value for testing the significance of AME estimates, Estpairwise, SEpairwise, Ppairwise—estimates of AME, standard error and p value, respectively, for pairwise comparisons between Placebo and Probiotic group (Placebo minus Probiotic).